Coronary

View the latest content related to this topic

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

(UPDATED) Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

Michael O'Riordan

April 22, 2025

Slides

See all

Presentation ACC 2025

Outcomes after FFR-Guided PCI vs. CABG: Final 5-Year Follow-up of the FAME 3 Trial

Presenter: William Fearon

March 30, 2025

Presentation ACC 2025

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Presenter: Darren K. McGuire

March 29, 2025

Presentation ACC 2025

Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial

Presenter: Joo-Yong Hahn

March 29, 2025

Presentation ACC 2025

Dual Antiplatelet Therapy After PCI According To Bleeding Risk: HOST-BR RCT

Presenter: Hyo-Soo Kim

March 29, 2025

Presentation CTO 2025

Efficacy and Safety of Left Ventricular Assist Devices on Clinical Outcomes in High-Risk Percutaneous Coronary Interventions

Presenter: Ogechukwu Samuel Obi

March 01, 2025

News

See all

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

By Michael O'Riordan

April 22, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

By L.A. McKeown

April 18, 2025

News Daily News

Black Adults Face CV Mortality Beyond Their Predicted Risk

By Caitlin E. Cox

April 18, 2025

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

By L.A. McKeown

April 15, 2025

News Conference News ACC 2025

RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up

By Michael O'Riordan

April 08, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Coronary

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Slides

Outcomes after FFR-Guided PCI vs. CABG: Final 5-Year Follow-up of the FAME 3 Trial

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial

Dual Antiplatelet Therapy After PCI According To Bleeding Risk: HOST-BR RCT

Efficacy and Safety of Left Ventricular Assist Devices on Clinical Outcomes in High-Risk Percutaneous Coronary Interventions

News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

April 2025 Dispatch for the CV Team

Black Adults Face CV Mortality Beyond Their Predicted Risk

Cardiotoxicity Rare With Common GI Chemotherapy

RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Coronary

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content